MwanzoDEMG • LON
add
Deltex Medical Group plc
Bei iliyotangulia
GBX 0.080
Bei za mwaka
GBX 0.072 - GBX 0.20
Thamani ya kampuni katika soko
1.52M GBP
Wastani wa hisa zilizouzwa
1.35M
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
LON
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(GBP) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | elfu 532.00 | 0.47% |
Matumizi ya uendeshaji wa biashara | elfu 576.50 | 0.70% |
Mapato halisi | elfu -273.00 | -1.68% |
Kiwango cha faida halisi | -51.32 | -1.20% |
Mapato kwa kila hisa | — | — |
EBITDA | elfu -201.50 | -6.33% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(GBP) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | elfu 326.00 | 204.67% |
Jumla ya mali | 5.50M | -7.47% |
Jumla ya dhima | 2.81M | -31.48% |
Jumla ya hisa | 2.69M | — |
hisa zilizosalia | 1.89B | — |
Uwiano wa bei na thamani | ∞ | — |
Faida inayotokana na mali | -10.05% | — |
Faida inayotokana mtaji | -11.83% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(GBP) | Jun 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | elfu -273.00 | -1.68% |
Pesa kutokana na shughuli | elfu -217.50 | -42.62% |
Pesa kutokana na uwekezaji | elfu 1.00 | 100.83% |
Pesa kutokana na ufadhili | elfu 21.50 | -77.37% |
Mabadiliko halisi ya pesa taslimu | elfu -189.50 | -4.12% |
Mtiririko huru wa pesa | elfu -113.12 | 53.54% |
Kuhusu
Deltex Medical Group is a medical technology company based in Chichester that produces blood monitoring and fluid management equipment for use in surgical operations.
It has sold 3000 of its main product, the ultrasound probe CardioQ-ODM, which measures the rate of blood flow from the heart. The company claims that it has been shown to reduce postoperative complications and reduce length of hospital stay. According to the National Institute for Health and Care Excellence it could save £1000 per operation and could be used on more than 800,000 patients a year. As it is inserted into the gullet, it reduces the risk of infection that comes with monitoring using a tube inserted through a vein into the heart. Each probe costs about £100.
It secured approval from the NHS Supply Chain in 2012 after a tender process, to sell cardiac output monitoring equipment to the NHS in England, meaning that individual NHS trusts did not have to go through a tender process. In November 2016 an NHS hospital bought six, the largest order since 2014. The cash crisis affecting the NHS has meant that few machines have been bought. Wikipedia
Ilianzishwa
2000
Tovuti
Wafanyakazi
24